Quantum Genomics Société Anonyme (ALQGC.PA)
EUR 0.07
(0.0%)
EUR 0.07
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -119.17 Thousand EUR | 99.08% |
| 2022 | -12.89 Million EUR | 0.0% |
| 2021 | - EUR | -100.0% |
| 2020 | 1.74 Million EUR | 424.61% |
| 2019 | 332.97 Thousand EUR | -21.08% |
| 2018 | 421.9 Thousand EUR | 123.36% |
| 2017 | 188.88 Thousand EUR | -81.32% |
| 2016 | 1.01 Million EUR | 7218.57% |
| 2015 | 13.81 Thousand EUR | 0.0% |
| 2014 | - EUR | -100.0% |
| 2013 | 58.98 Thousand EUR | -65.04% |
| 2012 | 168.75 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - EUR | 0.0% |
| 2023 FY | - EUR | 100.0% |
| 2023 Q4 | -119.17 Thousand EUR | 0.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q2 | 1.00 EUR | 0.0% |
| 2022 FY | -12.89 Million EUR | 0.0% |
| 2022 Q4 | - EUR | 0.0% |
| 2021 FY | - EUR | -100.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2021 Q4 | - EUR | 0.0% |
| 2020 Q4 | 1.74 Million EUR | 0.0% |
| 2020 FY | 1.74 Million EUR | 424.61% |
| 2020 Q2 | 1.07 Million EUR | 0.0% |
| 2019 FY | 332.97 Thousand EUR | -21.08% |
| 2019 Q2 | 553.97 Thousand EUR | 0.0% |
| 2019 Q4 | 332.97 Thousand EUR | 0.0% |
| 2018 Q4 | 421.9 Thousand EUR | 0.0% |
| 2018 FY | 421.9 Thousand EUR | 123.36% |
| 2018 Q2 | 138.53 Thousand EUR | 0.0% |
| 2017 Q2 | 449.37 Thousand EUR | 0.0% |
| 2017 FY | 188.88 Thousand EUR | -81.32% |
| 2017 Q4 | 188.88 Thousand EUR | 0.0% |
| 2016 Q2 | 124.91 Thousand EUR | 0.0% |
| 2016 FY | 1.01 Million EUR | 7218.57% |
| 2016 Q4 | 1.01 Million EUR | 0.0% |
| 2015 Q4 | 13.81 Thousand EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2015 FY | 13.81 Thousand EUR | 0.0% |
| 2014 Q4 | - EUR | 0.0% |
| 2014 Q2 | 1.00 EUR | 0.0% |
| 2014 FY | - EUR | -100.0% |
| 2013 FY | 58.98 Thousand EUR | -65.04% |
| 2013 Q4 | 779.74 Thousand EUR | 0.0% |
| 2012 FY | 168.75 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 153.926% |
| ABIVAX Société Anonyme | 1.00 EUR | 11917700.0% |
| Adocia SA | 272 Thousand EUR | 143.815% |
| Aelis Farma SA | 53 Thousand EUR | 324.86% |
| Biophytis S.A. | - EUR | Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 106.845% |
| genOway Société anonyme | 982.75 Thousand EUR | 112.127% |
| IntegraGen SA | 311.44 Thousand EUR | 138.265% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | 172.394% |
| Neovacs S.A. | - EUR | Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 89.25% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 109.732% |
| Sensorion SA | - EUR | Infinity% |
| Theranexus Société Anonyme | - EUR | Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | 230.963% |
| Valbiotis SA | 1 Million EUR | 111.858% |
| TheraVet SA | 123.34 Thousand EUR | 196.622% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | 11917700.0% |
| argenx SE | 281.12 Million EUR | 100.042% |
| BioSenic S.A. | - EUR | Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 109.458% |
| DBV Technologies S.A. | 1.00 USD | 11917700.0% |
| Galapagos NV | 73.97 Million EUR | 100.161% |
| Genfit S.A. | 4000.00 EUR | 3079.4% |
| GeNeuro SA | - EUR | Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | 11917700.0% |
| Innate Pharma S.A. | 1.00 EUR | 11917700.0% |
| Inventiva S.A. | 417 Thousand EUR | 128.579% |
| MaaT Pharma SA | 190 Thousand EUR | 162.724% |
| MedinCell S.A. | -6.71 Million EUR | 98.225% |
| Nanobiotix S.A. | 200 Thousand EUR | 159.588% |
| Onward Medical N.V. | 936 Thousand EUR | 112.732% |
| Oryzon Genomics S.A. | 6029.00 EUR | 2076.713% |
| OSE Immunotherapeutics SA | - EUR | Infinity% |
| Oxurion NV | 128 Thousand EUR | 193.106% |
| Pharming Group N.V. | 51.38 Million EUR | 100.232% |
| Poxel S.A. | 2.95 Million EUR | 104.032% |
| GenSight Biologics S.A. | 1.00 EUR | 11917700.0% |
| Transgene SA | - EUR | Infinity% |
| Financière de Tubize SA | - EUR | Infinity% |
| UCB SA | 1.03 Billion EUR | 100.012% |
| Valneva SE | 44.46 Million EUR | 100.268% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | 11917700.0% |